​2024

1. The antidepressant effects of vaporized N, N-Dimethyltryptamine: a preliminary report in treatment-resistant depressionM Falchi-Carvalho, H Barros, R Bolcont, S Laborde, I Wiessner, SRB Silva, ... medRxiv, 2024.01. 03.23300610.

2. Safety and tolerability of inhaled N, N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial. alchi-Carvalho M, Wießner I, Silva SR, Maia LO, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R. European Neuropsychopharmacology. 2024 Mar 1;80:27-35.

3. Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study. TA Sanchez, LR Ramos, F Araujo, EE Schenberg, M Yonamine, I Lobo, ... Journal of Ethnopharmacology, 2024, 320, 117430.

​

2023

1. A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depressionL Cruz, B Bienemann, F Palhano-Fontes, LF Tófoli, DB Araújo, ...
   Scientific Reports 13 (1), 19635.

2. LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals. Wießner I, Falchi M, Daldegan-Bueno D, Palhano-Fontes F, Olivieri R, Feilding A, Araujo DB, Ribeiro S, Mota NB, Tófoli LF. European Neuropsychopharmacology. 2023 Mar 1;68:89-104.

3. The DEA report on ayahuasca risks: “Science” in service of prohibition? B Labate, AO Ermakova, J Sloshower, N Galvão-Coelho, ...Journal of Psychedelic Studies 2023, 7 (2), 81-89.

4. LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. I Wießner, M Falchi, F Palhano-Fontes, A Feilding, S Ribeiro, LF Tófoli
   Psychological medicine, 2023, 53 (4), 1151-1165.

5. In vivo mapping of pharmacologically induced functional reorganization onto the human brain’s neurotransmitter landscape. AI Luppi, JY Hansen, R Adapa, RL Carhart-Harris, L Roseman, ...Science advances 2023, 9 (24), eadf8332.

6. Information parity increases on functional brain networks under influence of a psychedelic substanceA Viol, GM Viswanathan, O Soldatkina, F Palhano-Fontes, H Onias, ... Journal of Physics: Complexity 2023, 4 (1), 01LT02.

7. Repeated ayahuasca use increases structural covariance in networks associated with ‘self’processingA Piot, J Bouso, D Araujo, J Skipper. Language, Action and Brain Lab, 2023 1-5.

8. Ayahuasca's therapeutic potential: What we know–and what notLO Maia, D Daldegan-Bueno, I Wießner, DB Araujo, LF Tófoli. European neuropsychopharmacology, 2023, 66, 45-61.

9. Psychedelic science and Indigenous shamanism: an urgent dialogue. A Omágua-Kambeba, BC Labate, S Ribeiro. Nature Mental Health, 2023, 1 (11), 815-816.

​

2022

1. Moderators of ayahuasca’s biological antidepressant action. Sousa GM, de Oliveira Tavares VD, de Menezes Galvão AC, de Almeida RN, Palhano-Fontes F, Lobão-Soares B, de Morais Freire FA, Nunes EA, Maia-de-Oliveira JP, Perkins D, Sarris J. Frontiers in Psychiatry. 2022 Dec 5;13:2753.

2. Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior. de Meiroz Grilo ML, de Sousa GM, de Mendonça LA, Lobão-Soares B, de Sousa MB, Palhano-Fontes F, de Araujo DB, Perkins D, Hallak JE, Galvão-Coelho NL. Frontiers in Behavioral Neuroscience. 2022.

3. LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking. Wießner I, Falchi M, Maia LO, Daldegan-Bueno D, Palhano-Fontes F, Mason NL, Ramaekers JG, Gross ME, Schooler JW, Feilding A, Ribeiro S. Journal of Psychopharmacology. 2022;36(3):348-59.

4. Preliminary evidence of links between ayahuasca use and the corpus callosum. O Simonsson, JC Bouso, F Kurth, DB Araújo, C Gaser, J Riba, E Luders. Frontiers in Psychiatry 2022, 13, 1002455.

5. Nootropic effects of LSD: Behavioral, molecular and computational evidence. IM Ornelas, FA Cini, I Wießner, E Marcos, DB Araújo, L Goto-Silva, ... Experimental neurology 2022, 356, 114148.

6. LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility. I Wießner, R Olivieri, M Falchi, F Palhano-Fontes, LO Maia, A Feilding, ... European Neuropsychopharmacology. 2022, 58, 7-19.

 

2021

1. Ayahuasca for the treatment of depression. F Palhano-Fontes, BL Soares, NL Galvão-Coelho, E Arcoverde, ...Disruptive Psychopharmacology, 2022, 113-124.

2. Low-dose LSD and the stream of thought: increased discontinuity of mind, deep thoughts and abstract flow. Wießner I, Falchi M, Palhano-Fontes F, Oliveira Maia L, Feilding A, Ribeiro S, Bezerra Mota N, Araujo DB, Tófoli LF. Psychopharmacology. 2021;239(6):1721-33.

3. Física estatística aplicada à neurociência de estados alterados: o cérebro sob influência de psicodélicos. A Viol, H Felippe Jr, F Palhano-Fontes, H Onias, DB de Araujo, ...
   Revista Brasileira de Ensino de Física, 2021, 43, e20200440.

4. Biological and psychological mechanisms underlying the therapeutic use of ayahuasca. DB De Araújo, LF Tófoli, S Rehen, S Ribeiro. Handbook of medical hallucinogens, 2021, 277-93.

5. Recent evidence on the antidepressant effects of ayahuasca. F Palhano-Fontes, S Mota-Rolim, B Lobão-Soares, N Galvão-Coelho, ... Ayahuasca healing and science, 2021, 21-41.

6. Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)RG Dos Santos, DB Araujo, RF Sanches, JE Hallak. Brazilian Journal of Psychiatry, 2021, 43, 565-566.

​

2020

1. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca. NL Galvão-Coelho, AC de Menezes Galvão, RN de Almeida, … Journal of Psychopharmacology, 2020, 34 (10), 1125-1133.

2. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks. L Pasquini, F Palhano-Fontes, DB Araujo. Journal of Psychopharmacology, 2020, 34 (6), 623-635.

3. The impact of ayahuasca on suicidality: Results from a randomized controlled trial. RJ Zeifman, F Palhano-Fontes, J Hallak, E Arcoverde, JP Maia-Oliveira, … Frontiers in pharmacology 10, 1325.

4. The dream of god: how do religion and science see lucid dreaming and other conscious states during sleep?SA Mota-Rolim, K Bulkeley, S Campanelli, B Lobão-Soares, ...Frontiers in Psychology, 2021, 11, 555731.

5. Changes in cortisol but not in brain-derived neurotrophic factor modulate the association between sleep disturbances and major depression. GTP Santiago, AC de Menezes Galvão, RSNB De Almeida, ... Frontiers in behavioral neuroscience, 2020, 14, 44.

6. Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMTJ Winne, BC Boerner, T Malfatti, E Brisa, J Doerl, I Nogueira, KE Leão, ... Experimental Neurology, 2020, 326, 113175

​

2019

1. Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial. Frontiers in Psychology, 2019, v. 10, p. 1-13, 2019. Almeida RN; Galvao ACM; Silva FS; Silva EAS; Palhano-Fontes FX; de Araujo DB; Soares BL; Coelho NLG.

2. Is perception the missing link between creativity, curiosity and schizotypy? Evidence from spontaneous eye-movements and responses to auditory oddball stimuliME Gross, DB Araujo, CM Zedelius, JW Schooler. NeuroImage, 2019, 202, 116125.

3. Evidence for the therapeutic effects of Ayahuasca. DB de Araújo. Advances in psychedelic medicine State-of-the-art therapeutic applications 2020.

4. Characterizing complex networks using entropy-degree diagrams: unveiling changes in functional brain connectivity induced by Ayahuasca. A Viol, F Palhano-Fontes, H Onias, DB de Araujo, P Hövel, ... Entropy, 2020, 21 (2), 128.

5. Acute effects of ayahuasca in a juvenile non-human primate model of depression. FS Da Silva, EAS Silva, GM Sousa, JP Maia-de-Oliveira, ... Brazilian Journal of Psychiatry, 2019, 41, 280-288.

​

2018

1. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Osorio FL, Sanches R, dos Santos RG, Tófoli LF, Silveira GO, Yonamine M, Riba J, Santos FR, Silva-Junior AA, Alchieri JC, Galvao-Coelho N, Lobão-Soares B, Hallak JEC, Arcoverde E, Maia-de-Oliveira JP and Araujo DB.  Psychological Medicine, 2018, v. 1, p. 1-9.

2. Cortisol Modulation by Ayahuasca in Patients with Treatment-Resistant Depression and Healthy Controls. Galvão ACM, de Almeida RN, Silva EA, dos Santos F, Fúlvio AM, Palhano-Fontes F, Onias H, Arcoverde E, Maia-De-Oliveira JP, de Araujo DB, Lobão-Soares B, Galvão-Coelho NL. Frontiers in Psychiatry, 2018, 9, p. 185.

3. Acute effects of ayahuasca in a juvenile non-human primate model of depression. Braz J Psychiatry. 2018 Nov 8:0. doi: 10.1590/1516-4446-2018-0140.

4. A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrusRV Lima da Cruz, TC Moulin, LL Petiz, RN Leão. Frontiers in molecular neuroscience, 2018, 11, 312

​

2017

1. Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca. Viol A, Palhano-Fontes FX, Onias HHS, de Araujo DB, Viswanathan G. Scientific Reports, 2017, v. 7, p. e1-e13.

2. Assessing the psychedelic after-glow in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. Sampedro F, de la Fuente M, Valle M, Roberto N, Domínguez-Clavé E, Elices M, Luna LE, Crippa JAS, Hallak JEC, de Araujo DB; Friedlander P, Barker AS, Álvarez E, Soler J, Pascual JC, Feilding A, Riba J. Int. Jour Neuropsychopharmacology, 2017, v. 1, p. 1-14.

3. Short-term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. Dakic V, Minardi J, Costa R, Maciel R, de Araujo DB, Ribeiro S, Souza D, Rehen S. Scientific Reports, v. 7, p. 12863, 2017.

​

2016

1. Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression. Sanches RF, Osorio FL, dos Santos RG, Macedo LRH, Maia-De-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JAS, Hallak JEC. Journal of Clinical Psychopharmacology, 2016, 36, p. 77-81.

2. Treating addiction: Perspectives from EEG and imaging studies on psychedelicsLF Tófoli, DB de Araujo. International review of neurobiology, 2016, 129, 157-185.

​

2015

1. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Osorio FL, Sanches RF, Macedo L, Santos RG, Oliveira JPM, Wichert-Ana L, de Araujo DB, Riba J, Crippa J, Hallak JEC. Revista Brasileira de Psiquiatria, 2015, 37, 13-20.

2. The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network. Palhano-Fontes FX, Andrade KC, Tofoli LF, Santos AC, Crippa JAS, Hallak JEC, Ribeiro S, de Araujo DB. Plos One, 2015, 10, e0118143.

3. Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Bouso JC, Palhano-Fontes FX, Rodriguez-Fornells A, Ribeiro S, Sanches RF, Crippa JAS, Hallak JEC, de Araujo DB, Riba J. European Neuropsychopharmacology, 2015, 25(4), 483-492.

​

2014

1. The therapeutic potentials of ayahuasca in the treatment of depressionF Palhano-Fontes, JC Alchieri, JPM Oliveira, BL Soares, JEC Hallak, ...The therapeutic use of ayahuasca, 2014, 23-39.

​

2012

1. Seeing With the Eyes Shut: Neural Basis of Enhanced Imagery Following Ayahuasca Ingestion. de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, Martinis BS, Crippa JA, Hallak JEC, Santos AC. Human Brain Mapping, 2012, 33, 2550-2560.

​

2009

1. Effects of the Amazonian psychoactive plant beverage ayahuasca on prefrontal and limbic regions during a language task: a fMRI study. D Almeida Prado, J Pinto, J Crippa, A Santos, S Ribeiro, D Araujo, ... European Neuropsychopharmacology, 2009, 19, S314-S315